Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose and treat this complex disease. As one of 70 National Cancer Institute-Designated Cancer Centers, Hollings continues to attract top cancer researchers from leading institutions across the country who are conducting research in the community, laboratory and clinic.
Hollings' four research programs center around cancer biology, cancer immunology, developmental cancer therapeutics and cancer control.
Hollings supports shared resources that are efficient, cost-effective and provide the latest industry standards for enhanced scientific productivity.
HCC encourages applicants from diverse fields of study in either the basic, translational, population or clinical sciences to apply.
Hollings offers a number of intramural support opportunities for students, postdoctoral trainees, and faculty conducting cancer-related research and clinical services.
The Clinical Trials Office (CTO) provides a centralized office for conducting cancer clinical trials at the Medical University of South Carolina. The purpose of the CTO is to provide an effective and efficient infrastructure to support HCC investigators in developing, implementing and reporting on all cancer clinical research studies at MUSC.
Notification of intent to submit an application for the American Cancer Society Institutional Research Grant (ACS IRG) is due by Friday, September 28, 2018, by 3:00 p.m.
Application deadlines vary among programs. Please see the individual award pages for their specific dates.
The Hollings Cancer Center seeks MUSC faculty who have an interest in cancer research and provides opportunities for interactions and collaboration among investigators with common interests. Hollings members are given priority access to HCC-supported Shared Resources and are eligible to apply for pilot project funding.